Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ESTRATEST in Menopausal Symptoms
NCT00141544Phase 2Terminated
- Sponsor
- Solvay
- Start
- Jul 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of esterified estrogens + methyltestosterone in menopause (2 arms), sponsored by Solvay. Primary endpoint: Menopause Rating Scale Total Score at 12 weeks. Started Jul 2004; status: terminated.
02
Drugs
esterified estrogens + methyltestosterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00141544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141544.